Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

ARCT 2304

Next Previous
X
Search
Drug Profile

ARCT 2304

Alternative Names: ARCT-2304; LUNAR®-FLU; Self-Amplifying mRNA pandemic Influenza vaccine

Latest Information Update: 18 Nov 2024

Price :

$50 *

Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Arcturus Therapeutics
  • Class Influenza virus vaccines; RNA vaccines
  • Mechanism of Action Dendritic cell modulators; Protein stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No
  • Available For Licensing Yes

Highest Development Phases

  • Preclinical Influenza virus infections

Most Recent Events

  • 11 Nov 2024 US FDA approves IND application for ARCT 2304 for influenza virus infection caused by H5N1 virus
  • 19 Sep 2024 Arcturus Therapeutics plans a phase I trial for Influenza virus infections (Prevention) in December 2024 (IM, Injection) (NCT06602531)
  • 05 Aug 2024 ARCT 2304 is available for licensing as of 05 Aug 2024. https://arcturusrx.com/mrna-medicines-pipeline/

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top